GNH USA

Europe — EMA

Mycosyst-Gyno (Fluconazole)

GNH USA supplies Mycosyst-Gyno (Fluconazole), a triazole antifungal for vulvovaginal candidiasis and genital tract Candida infections.

Request sourcing

1
Pack/s

What is Fluconazole?

Fluconazole, the active ingredient in Mycosyst-Gyno, is a triazole antifungal presented as an oral formulation for systemic use. It is indicated for the treatment of fungal infections of the genital tract, especially vulvovaginal candidiasis, in adult women and other patients requiring antifungal therapy.

GNH USA supplies Mycosyst-Gyno as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing products sourced from the European Union market to meet global demand.

What is Fluconazole used for?

Mycosyst-Gyno (fluconazole) is used to treat fungal infections within the genital tract and related conditions. - Vulvovaginal candidiasis: relieves symptoms and eradicates Candida species causing infection. - Candidal infection of the genital tract: eliminates the pathogen and prevents spread. - Recurrent vulvovaginal candidiasis: reduces frequency of episodes when prescribed for maintenance therapy.

What are the side effects of Fluconazole?

Fluconazole may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Abdominal pain: discomfort in the upper abdomen. - Headache: transient cranial pain. - Diarrhea: loose stools. - Rash: skin redness or itching. - Taste alteration: metallic or altered taste perception.

Serious or Rare Side Effects: - Hepatotoxicity: signs of liver injury such as jaundice. - Severe allergic reactions: including anaphylaxis. - Stevens‑Johnson syndrome: severe skin blistering. - Liver failure: acute hepatic dysfunction. - Blood disorders: neutropenia or thrombocytopenia. - Cardiac arrhythmias: QT prolongation in susceptible individuals.

What precautions apply to Fluconazole?

Before prescribing Mycosyst-Gyno, clinicians should consider several safety aspects. - Liver function assessment: evaluate hepatic enzymes prior to initiation. - Renal impairment monitoring: adjust use in patients with reduced kidney function. - Drug interaction review: check concomitant medications that affect CYP enzymes. - Hypersensitivity check: avoid in patients with known fluconazole allergy. - Pregnancy and lactation counseling: weigh benefits against potential risks. - Store at below 25°C: keep in the original pack, protect from moisture.

What does Fluconazole interact with?

Fluconazole interacts with several medicines; understanding the level of interaction helps guide safe use.

Major Interactions (Avoid): - Warfarin: may increase anticoagulant effect and bleeding risk. - Phenytoin: fluconazole can raise phenytoin levels, leading to toxicity. - Carbamazepine: may cause elevated carbamazepine concentrations.

Moderate Interactions (Monitor Closely): - Oral contraceptives: reduced efficacy, consider alternative contraception. - Statins (e.g., simvastatin): increased risk of myopathy. - NSAIDs: potential for enhanced renal effects. - Antidiabetic agents (e.g., sulfonylureas): may require dose adjustment.

Frequently asked questions

What is Mycosyst-Gyno used for?+
Mycosyst-Gyno contains fluconazole, an antifungal medication used primarily to treat vulvovaginal candidiasis and other Candida infections of the genital tract. It works by eliminating the fungal organism responsible for the infection, thereby relieving symptoms such as itching, discharge, and irritation.
How does fluconazole work in Mycosyst-Gyno?+
Fluconazole inhibits the fungal enzyme lanosterol 14α‑demethylase, which is essential for producing ergosterol, a key component of fungal cell membranes. By blocking ergosterol synthesis, the drug compromises membrane integrity, leading to inhibited growth and eventual death of the fungus.
What is the usual dose of Mycosyst-Gyno?+
The specific dose of Mycosyst-Gyno is determined by the prescribing clinician based on the infection type, severity, patient weight, renal and hepatic function, and other individual factors. Healthcare professionals should follow current clinical guidelines and adjust the regimen as needed.
Is Mycosyst-Gyno safe during pregnancy or breastfeeding?+
Safety of fluconazole during pregnancy or lactation depends on the dose and duration of therapy. Single low‑dose treatments are sometimes considered acceptable, but higher or prolonged courses may pose risks. Physicians should evaluate the benefit‑risk ratio and discuss alternatives when appropriate.
How do I order Mycosyst-Gyno from GNH USA?+
To order Mycosyst-Gyno, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.
How does Mycosyst-Gyno compare with other antifungal agents?+
Fluconazole, the active ingredient in Mycosyst-Gyno, offers oral convenience and a broad spectrum against Candida species, often preferred over older azoles like ketoconazole due to better tolerability and fewer drug‑interaction concerns. Compared with newer agents such as itraconazole, fluconazole has a simpler dosing schedule but may be less effective against resistant strains.
What are the storage and handling requirements for Mycosyst-Gyno?+
Mycosyst-Gyno should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keeping the product in a dry, cool environment helps maintain its stability and potency throughout its shelf life.
How is Mycosyst-Gyno administered?+
Mycosyst-Gyno is taken orally, usually as a single dose or a short course as directed by a healthcare professional. The tablet should be swallowed whole with water and can be taken with or without food, unless otherwise advised by the prescriber.
What are the most serious risks associated with Mycosyst-Gyno?+
Serious risks include hepatotoxicity, severe allergic reactions such as anaphylaxis, and rare skin disorders like Stevens‑Johnson syndrome. Patients should be instructed to seek immediate medical attention if they experience signs of liver injury (e.g., jaundice), rash, or difficulty breathing.
Who should not use Mycosyst-Gyno?+
Mycosyst-Gyno is contraindicated in individuals with a known hypersensitivity to fluconazole or any other azole antifungal. Caution is also advised for patients with severe liver disease, and it should be avoided in those taking medications that have a high risk of dangerous interactions unless closely monitored.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Fluconazole
Route
Oral Use
Manufacturer
Gedeon Richter Plc.
Origin
EU

Related products